Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells.
about
T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.Cellular-based immunotherapies for patients with glioblastoma multiforme.Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigenOptimizing the process of nucleofection for professional antigen presenting cells.
P2860
Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Therapeutical doses of temozol ...... cells and CD8+ T cells.
@en
Therapeutical doses of temozol ...... cells and CD8+ T cells.
@nl
type
label
Therapeutical doses of temozol ...... cells and CD8+ T cells.
@en
Therapeutical doses of temozol ...... cells and CD8+ T cells.
@nl
prefLabel
Therapeutical doses of temozol ...... cells and CD8+ T cells.
@en
Therapeutical doses of temozol ...... cells and CD8+ T cells.
@nl
P2093
P356
P1476
Therapeutical doses of temozol ...... cells and CD8+ T cells.
@en
P2093
Anita Schmitt
Anne Enders
Carl Friedrich Classen
Mathias Freund
Michael Linnebacher
Michael Schmitt
Rosaely Casalegno-Garduno
P304
P356
10.3892/IJO.2011.1269
P577
2011-11-23T00:00:00Z